Net Income

Medicus Pharma's microneedle patch for basal cell carcinoma clears nearly three-quarters of lesions, offering a potential non-surgical alternative to the scalpel.

The travel giant reports a $245M profit swing and doubles its share buyback, fueled by its CWT merger and a bold new AI-driven strategy for 2026.

A new surgical robot from Beijing's Healinno Tech uses AI and a high-pressure waterjet to treat prostate issues with unprecedented precision and safety.

With new data on CUE-401, a novel therapy inspired by Nobel-winning science, Cue Biopharma makes a high-stakes play to redefine autoimmune treatment.

As owners demand healthier options, Solid Gold's national launch at Petco reveals the lucrative trend of personalizing pet nutrition.

Founded by Emma Heming Willis, Make Time Wellness unveils three new products, tapping into a booming market with science-backed solutions for women's brain health.

Facing volatile markets, AVAX One pushes for regulatory clarity at the DC Blockchain Summit, aiming to legitimize Avalanche for institutional investors.

At Legalweek 2026, HaystackID unveiled major AI upgrades for its CoreFlex platform, targeting complex evidence from Slack and Microsoft 365.

Despite a massive paper loss, Sharplink amassed a huge ETH treasury and grew staking revenue, testing a new model for public company crypto exposure.

The clean energy firm reports strong Q1 revenue and eyes the data center market, but a shrinking backlog and wider gross loss present a mixed picture.

Despite lower annual revenue, 3D Systems reports a full-year profit driven by a major divestiture and strong growth in healthcare and aerospace sectors.

A year after rebranding from FibroGen, Kyntra Bio's first full-year report will test if its lean strategy can fuel its ambitious oncology pipeline.

With backing from Samsung and NVIDIA, Nota AI showcases how its optimization tech brings powerful LLMs and vision AI to real-world edge devices.

The massive rollout of hellocare.ai's platform aims to enhance patient safety and ease nursing shortages, marking a major leap into the future of healthcare.

A new survey reveals firms are rushing to deploy AI without proper data management, accumulating a costly and dangerous 'technical debt' that threatens innovation.

With one trial halted and another beginning, the company focuses its cash and hopes on BBI-940, a novel drug targeting a fundamental driver of cancer.

A new AI-designed drug shows promise in selectively burning fat while preserving muscle, with a potential twice-yearly dosing schedule for obesity.

Honored as a top SaaS leader, April Stiles is pioneering responsible AI in healthcare. See how her vision is driving growth and innovation at Perspecta.

With 300 million monthly players, a simple puzzle game is quietly dominating the app stores. Here’s how Block Blast! turned relaxation into a global hit.

With record backlogs and surging demand from AI and energy transition, Quanta's March 31st event will reveal new targets shaping the future of infrastructure.